C M Cabrera
Overview
Explore the profile of C M Cabrera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
262
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cabrera C, Palacios-Canas A, Joyanes-Romo J, Urra J, Mur P
Mol Immunol
. 2022 Jun;
149:59-65.
PMID: 35749834
Most patients with Hymenoptera venom allergy (HVA) to vespid venoms present double sensitization by specific IgE (sIgE)-mediated cross-reactivity. Thus, it is mandatory could discriminate between a true double and primary...
2.
Urra J, Cabrera C, Porras L, Rodenas I
Clin Immunol
. 2020 Jun;
217:108486.
PMID: 32479985
The lymphopenia exhibited in patients with COVID-19 has been associated with a worse prognosis in the development of the disease. To understand the factors associated with a worse evolution of...
3.
Cabrera C, Fernandez-Grande E, Urra J
Lupus
. 2016 Feb;
25(9):980-7.
PMID: 26846693
Nucleolar staining of antinuclear antibodies (ANAs) is not exclusive to patients suffering systemic sclerosis (SSc) since it can occur in other autoimmune diseases, such as systemic lupus erythematosus (SLE). The...
4.
Urra J, Carrasco P, Feo-Brito F, de la Roca F, Guerra F, Cabrera C
J Investig Allergol Clin Immunol
. 2014 May;
24(2):98-105.
PMID: 24834772
Background: Allergen-specific immunotherapy (SIT) is the only intervention for IgE-mediated respiratory disorders. Objective: The aim of the study was to investigate the immunological modifications induced by SIT in patients allergic...
5.
Cabrera C, Urra J, Carreno A, Zamorano J
Scand J Immunol
. 2013 Jun;
78(3):306-12.
PMID: 23790231
Systemic lupus erythematosus (SLE) is an autoimmune systemic disease caused as a result of an imbalance of Th1-/Th2-type cytokines. The soluble form of CD30 (CD30s) released from peripheral blood cells...
6.
Cabrera C, Cobo F, Nieto A, Cortes J, Montes R, Catalina P, et al.
Cytotechnology
. 2008 Nov;
51(2):45-50.
PMID: 19002894
Cell line cross-contamination is a phenomenon that arises as a result of the continuous cell line culture. It has been estimated that around 20% of the cell lines are misidentified,...
7.
Cabrera C
Scand J Immunol
. 2007 May;
65(6):487-93.
PMID: 17523940
During the assembly of the HLA class I molecules with peptides in the peptide-loading complex, a series of transient interactions are made with ER-resident chaperones. These interactions culminate in the...
8.
Cabrera C, Nieto A, Cortes J, Montes R, Catalina P, Cobo F, et al.
Cell Biol Int
. 2007 Apr;
31(9):1072-8.
PMID: 17459733
Human embryonic stem cells (hESCs) represent a promise for future strategies of tissue replacement. However, there are different issues that should be resolved before these cells can be used in...
9.
Nieto A, Cabrera C, Catalina P, Cobo F, Barnie A, Cortes J, et al.
Cell Biol Int
. 2007 Jan;
31(3):269-78.
PMID: 17241790
Mitomycin C (MMC) treatment has been used to arrest cell proliferation but not much is known about the effect of MMC on human foreskin fibroblasts (HFF) used as feeders for...
10.
Nieto A, Cobo F, Barroso-Deljesus A, Barnie A, Catalina P, Cabrera C, et al.
Stem Cell Rev
. 2007 Jan;
2(2):117-26.
PMID: 17237550
Human embryonic stem cells (hESCs) have an unlimited capacity to proliferate by a self-renewal process and can be differentiated in the three germ layers, opening doors to new clinical therapies...